531 related articles for article (PubMed ID: 26122378)
1. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378
[TBL] [Abstract][Full Text] [Related]
2. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
3. A polysaccharide from Codonopsis pilosula roots attenuates carbon tetrachloride-induced liver fibrosis via modulation of TLR4/NF-κB and TGF-β1/Smad3 signaling pathway.
Meng X; Kuang H; Wang Q; Zhang H; Wang D; Kang T
Int Immunopharmacol; 2023 Jun; 119():110180. PubMed ID: 37068337
[TBL] [Abstract][Full Text] [Related]
4. Xia-Yu-Xue Decoction Inhibits Intestinal Epithelial Cell Apoptosis in CCl4-Induced Liver Fibrosis.
Ma W; Tao L; Zhang W; Zhu Y; Xue D; Zhang J; Liu C
Cell Physiol Biochem; 2017; 44(1):333-344. PubMed ID: 29132134
[TBL] [Abstract][Full Text] [Related]
5. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo.
Wang H; Che J; Cui K; Zhuang W; Li H; Sun J; Chen J; Wang C
Phytomedicine; 2021 Jul; 88():153609. PubMed ID: 34126414
[TBL] [Abstract][Full Text] [Related]
6. Xiayuxue Decoction ([symbols; see text]) attenuates hepatic stellate cell activation and sinusoidal endothelium defenestration in CCl4-induced fibrotic liver of mice.
Zhang LJ; Sun MY; Ning BB; Zhang WM; Chen GF; Mu YP; Zhang H; Liu J; Bian YQ; Liu P
Chin J Integr Med; 2014 Jul; 20(7):516-23. PubMed ID: 24972579
[TBL] [Abstract][Full Text] [Related]
7. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
8. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin Attenuates Liver Fibrosis through Regulation of TGF-β1 Expression and Autophagy.
Mao Y; Zhang S; Yu F; Li H; Guo C; Fan X
Int J Mol Sci; 2015 Sep; 16(9):21911-30. PubMed ID: 26378522
[TBL] [Abstract][Full Text] [Related]
10. Calcitriol attenuates liver fibrosis through hepatitis C virus nonstructural protein 3-transactivated protein 1-mediated TGF β1/Smad3 and NF-κB signaling pathways.
Shi L; Zhou L; Han M; Zhang Y; Zhang Y; Yuan XX; Lu HP; Wang Y; Yang XL; Liu C; Wang J; Liang P; Liu SA; Liu XJ; Cheng J; Lin SM
World J Gastroenterol; 2023 May; 29(18):2798-2817. PubMed ID: 37274069
[TBL] [Abstract][Full Text] [Related]
11. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
12. Retraction Note: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
BMC Complement Med Ther; 2022 Sep; 22(1):236. PubMed ID: 36068510
[No Abstract] [Full Text] [Related]
13. PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis.
Yu Q; Cheng P; Wu J; Guo C
J Cell Mol Med; 2021 Feb; 25(3):1645-1660. PubMed ID: 33438347
[TBL] [Abstract][Full Text] [Related]
14. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
[TBL] [Abstract][Full Text] [Related]
15. Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells.
Zhang D; Zhang L; Chen G; Xu Y; Yang H; Xiao Z; Chen J; Mu Y; Zhang H; Liu W; Liu P
Pharm Biol; 2020 Dec; 58(1):1229-1243. PubMed ID: 33332219
[TBL] [Abstract][Full Text] [Related]
16. Effect of NLRC5 on activation and reversion of hepatic stellate cells by regulating the nuclear factor-κB signaling pathway.
Zhang YZ; Yao JN; Zhang LF; Wang CF; Zhang XX; Gao B
World J Gastroenterol; 2019 Jun; 25(24):3044-3055. PubMed ID: 31293340
[TBL] [Abstract][Full Text] [Related]
17. RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway.
Shi H; Duan X; Dong J; Tao Y; Lei Y
J Ethnopharmacol; 2024 May; 326():117963. PubMed ID: 38387680
[TBL] [Abstract][Full Text] [Related]
18. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
[TBL] [Abstract][Full Text] [Related]
19. DCDC2 inhibits hepatic stellate cell activation and ameliorates CCl
Liu QQ; Chen J; Ma T; Huang W; Lu CH
Sci Rep; 2024 Apr; 14(1):9425. PubMed ID: 38658618
[TBL] [Abstract][Full Text] [Related]
20. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
